Comparison of Adverse Events Associated With Use of Mefloquine and Combination of Chloroquine and Proguanil as Antimalarial Prophylaxis: Postal and Telephone Survey of Travellers

BMJ
doi 10.1136/bmj.313.7056.525
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Plasma and Whole Blood Mefloquine Concentrations During Treatment of Chloroquine-Resistant Falciparum Malaria With the Combination Mefloquine-Sulphadoxine-Pyrimethamine.

British Journal of Clinical Pharmacology
Pharmacology
1987English

Adverse Events and Concurrent Medications Associated With Parenteral Nutrition Use

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Malaria Chemoprophylaxis With a Proguanil - Chloroquine - Maloprim Combination in Papua New Guinea

Journal of the Royal Army Medical Corps
Medicine
1988English

Testing Survey Methodology to Measure Patients' Experiences and Views of the Emergency and Urgent Care System: Telephone Versus Postal Survey

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2010English

Comparison of Text-Messaging to Voice Telephone Interviews for Active Surveillance of Adverse Events Following Immunisation

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2015English

Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis

Clinical Breast Cancer
Cancer ResearchOncology
2016English

Patient Reports of Adverse Events Associated With Acupuncture Treatment: A Prospective National Survey

Quality and Safety in Health Care
2004English

Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy